THE FAT DESTROYER

FTTP (Adipotide)

Grade DUse Caution

Targeted fat destruction by cutting off blood supply to fat cells

Also known as: Adipotide; Prohibitin-Targeting Peptide

Weight Management
Metabolic Modulator
Anti-Aging & Longevity

Overview

FTTP (Fat-Targeted Therapeutic Peptide), also known as Adipotide, is a chimeric peptide that homes in on blood vessels feeding fat tissue and triggers their destruction. Without blood supply, fat cells die. In studies, it produced dramatic fat loss - but it also showed kidney toxicity, limiting its development.

Key Benefits & Mechanisms

Vascular Homing

Specifically targets blood vessels supplying fat tissue

Apoptosis Induction

Triggers cell death in fat tissue vasculature

Fat Cell Death

Adipocytes die when blood supply is cut off

Dosing Guide

Dosage

No established safe human dosing

Schedule

daily

Cycle

Research use only with renal monitoring

Pro Tip

NOT recommended for human use due to kidney risks

Safety Profile

D

High Risk

Use Caution

Showed significant fat loss but also kidney toxicity in animal studies.

SIGNIFICANT KIDNEY RISK. Development limited due to nephrotoxicity. Requires renal monitoring. Research use only.

Possible Side Effects

Kidney toxicity (nephrotoxicity)
Injection site reactions

What to Expect

Week 1-2

Fat tissue vascular disruption begins

Week 2-4

Significant fat loss observed in studies

Fat loss observed rapidly in studies but accompanied by organ damage risks.

Who Is This For

Research applications only
Severe obesity cases unresponsive to other treatments
NOT for general weight loss use

Research References

Related Peptides

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App